Industry appeals to DoP to keep new PLI scheme open for all
The drug industry has appealed to the Department of Pharmaceuticals (DoP) to allow all active pharmaceutical ingredients (APIs)/intermediates under category 2 of Rs. 15,000 crore production linked incentive (PLI) scheme as long as they are import substitution and there is domestic value addition of 70 per cent for chemical synthesis based bulk drugs and 90 per cent for fermentation based
Industry appeals to DoP to keep new PLI scheme open for all
The drug industry has appealed to the Department of Pharmaceuticals (DoP) to allow all active pharmaceutical ingredients (APIs)/intermediates under category 2 of Rs. 15,000 crore production linked incentive (PLI) scheme as long as they are import substitution and there is domestic value addition of 70 per cent for chemical synthesis based bulk
Pharma Ind appeals to DoP to keep new PLI scheme open for all
The drug industry has appealed to the Department of Pharmaceuticals (DoP) to allow all active pharmaceutical ingredients (APIs) / intermediates under category 2 of Rs. 15,000 crore production linked incentive (PLI) scheme as long as they are import substitution and there is domestic value addition of 70 per cent for chemical synthesis based bulk
Home | Department of Pharmaceuticals | Government of India
Subject:- Operational Guidelines for the Production Linked Incentive (PLI) Scheme for Pharmaceuticals — reg. The undersigned is directed to refer to the above-mentioned subject and state the following: Clause 2.15.1 may be read as under: 2.15.1, Ex enditure incurred on new Plant Machine E ui mentand Associated
Government issues Operational guidelines for PLI scheme
PLI scheme for bulk drugs or any other PLI scheme to high of the country and change India’s Comments a. The scheme may facilitate product diversification value goods in the pharmaceutical sector image as a manufacturer and exporter of drugs and medical devices. b. It would be advisable for the desired applicants to
- What is the last date to apply for Pharma PLI scheme?
- The last date for application for Pharma PLI scheme for bulk drugs, APIs/KSMs and drug intermediaries and for medical devices is November 27. The last date to apply for Medical Device & Bulk drug Parks is October 15. This has already been revised once as the initial deadline was September 24.
- What is the response to the four schemes launched by DOP?
- The initial response to the four schemes launched by the Department of Pharmaceuticals (DoP) for promoting domestic manufacturing of drugs, APIs/ KSMs and medical devices is quite encouraging.
- How many pharma companies have submitted applications to the DOP?
- CNBC-TV18 has learnt from top sources at the DoP that as many as 29 pharma companies have submitted their applications to the government and many more are soon likely to sign up.
